Aktuellt
SENASTE
Redeye reduces our short-term lower estimated number of systems to be sold during 2022e and, to an extent, in 2023e. The estimate changes lower our Base Case to SEK 6 (8) per share, partly also due to a higher risk-free rate in our model. We still see a compelling long-term case; however, with the financing sorted, the pathway to commercialization is more straightforward.
LÄS MER
